Yüklüyor......

Case report: 5-year progression free survival and complete liver response in a patient with metastatic breast cancer treated with everolimus plus exemestane

RATIONALE: Within a rapidly expanding therapeutic armamentarium, the combination of everolimus (Eve) plus exemestane (Exe) utility needs to be reinstated in hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2–) metastatic breast cancer (MBC). PATIENT CONCERNS: We...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Medicine (Baltimore)
Asıl Yazarlar: Krasniqi, Eriseld, Barchiesi, Giacomo, Mazzotta, Marco, Pizzuti, Laura, Villa, Alice, Barba, Maddalena, Vici, Patrizia
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Wolters Kluwer Health 2020
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7402792/
https://ncbi.nlm.nih.gov/pubmed/32756099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000021211
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!